3D Mammography (Tomosynthesis)
Pioneered at Mass General, 3D mammography, also known as tomosynthesis, produces a 3D view of breast tissue to improve breast-cancer screening and detection while reducing callbacks and anxiety for women.
BENEFITS:
- Improves radiologists’ ability to screen for and detect potential breast cancers.
- Helps radiologists pinpoint size, shape, and location of abnormalities.
- Can help distinguish harmless abnormalities from real tumors, leading to fewer callbacks and less anxiety for women.
INNOVATION:
- Pioneered at Mass General.
- Received FDA approval Feb. 11, 2011, following 10 years of research led by Mass General Breast Imagingteam.
- Mass General Imaging performed first clinical tomosynthesis exam in United States March 7, 2011.
AVAILABILITY:
- Tomosynthesis is complementary to standard mammography, which remains the “gold standard.”
- Experts expect tomosynthesis to eventually become the new gold standard.
- Tomosynthesis is performed along with a standard mammogram—at the same time on the same scanner.
- Tomosynthesis is available at Mass General in Boston, Mass General West Imaging – Waltham and at Mass General Imaging – Worcester
To learn more about the benefits and availability of 3D mammographay, click here.